back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-05-06 13:34 Tx date 2025-05-05 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
97 - Other
|
+5,506,372 vol |
6,892,653 | |
| Filed 2025-05-06 13:28 Tx date 2025-05-06 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
52 - Expiration of options
|
$-54,000
-30,000 vol $1.80 each |
3,737,500 | |
| Filed 2025-03-03 15:22 Tx date 2025-02-28 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
52 - Expiration of options
|
$-102,000
-600,000 vol $0.17 each |
3,767,500 | |
| Filed 2024-12-30 17:56 Tx date 2024-12-16 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
97 - Other
|
+1,225,000 vol |
1,225,000 | |
| Filed 2024-12-30 17:55 Tx date 2020-08-31 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-10-09 13:51 Tx date 2024-10-08 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$84,000
+600,000 vol $0.14 each |
4,367,500 | |
| Filed 2023-12-12 12:46 Tx date 2023-12-08 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
52 - Expiration of options
|
-200,000 vol |
3,767,500 | |
| Filed 2023-05-09 18:23 Tx date 2023-05-02 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$205,312
+2,737,500 vol $0.075 each |
3,967,500 | |
| Filed 2023-04-28 12:17 Tx date 2023-04-27 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
52 - Expiration of options
|
$-252,000
-400,000 vol $0.63 each |
1,230,000 | |
| Filed 2023-01-19 13:31 Tx date 2020-08-31 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,386,281 | ||
| Filed 2023-01-19 13:21 Tx date 2023-01-13 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,630,000 | |
| Filed 2023-01-19 13:21 Tx date 2022-03-01 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
1,230,000 | |
| Filed 2023-01-19 13:20 Tx date 2021-04-28 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
630,000 | |
| Filed 2023-01-19 13:17 Tx date 2020-12-09 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
230,000 | |
| Filed 2023-01-19 13:16 Tx date 2020-08-31 |
$BETR
BetterLife Pharma Inc. |
Sheshbaradaran, Hooshmand
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
30,000 |